Previous Close | 241.55 |
1-Year Change | 58.37% |
6-Months Change | 10.67% |
3-Months Change | 8.12% |
Moving Avg (50d) | 242.11 |
Moving Avg (200d) | 213.51 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 35.5B |
Beta (3-Years) | 0.88 |
Revenue Growth (ttm) | 20.71% |
Net Profit Margin (ttm) | 20.72% |
Return On Assets (ttm) | 13.45% |
EPS (ttm) | 6.16 |
PE Ratio (ttm) | 39.21 |
Dividend Yield | 0.75% |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |
ResMed Inc. is an American medical equipment company based in San Diego, California. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. ResMed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. ResMed also provides... Wikipedia